|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,015.00 DKK | +1.18% |
|
-2.47% | +34.74% |
| 10/12 | BillionToOne Q3 Swings to Profit, Revenue Rises; Shares Fall After Hours | MT |
| 09/12 | Genmab shares encouraging early-stage data on epcoritamab for RT patients | RE |
Main competitors
| Change | 5d. change | 1 months change | 3 months change | Varia. Jan 1. | 1-year change | 3-years change | 5-years change | 10-years change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +1.18% | -2.47% | +4.79% | +10.40% | +34.74% | +30.92% | -38.14% | -16.17% | +120.75% | 1.91TCr | |
| -1.40% | -4.14% | -0.42% | +15.97% | +26.57% | +30.89% | +100.37% | +211.23% | +7,688.72% | 5.49TCr | |
| -2.22% | -8.19% | -1.08% | +30.10% | +174.99% | +161.43% | +928.44% | +377.25% | +983.62% | 4.05TCr | |
| +0.63% | +5.85% | -0.75% | -13.50% | +68.51% | +60.00% | +15.94% | +1.50% | - | 3.91TCr | |
| -0.12% | -1.03% | -8.88% | -5.21% | -15.99% | -18.07% | -43.78% | -26.10% | - | 2.3TCr | |
| -0.30% | +1.64% | +0.72% | -7.00% | +90.66% | +81.76% | -35.43% | -58.92% | - | 1.78TCr | |
| +0.51% | -4.86% | +2.62% | -8.07% | +93.41% | +85.61% | +192.40% | +307.64% | - | 1.38TCr | |
| +5.41% | -2.34% | -1.97% | +1.90% | +0.53% | -0.17% | +357.65% | +270.66% | +64.14% | 1.38TCr | |
| +1.31% | -6.99% | +1.16% | -14.98% | +155.73% | +120.02% | - | - | - | 1.24TCr | |
| -0.26% | -4.73% | +11.41% | +28.45% | +79.04% | +76.64% | +725.69% | +358.71% | - | 1.25TCr | |
| -1.91% | -6.68% | -0.82% | +8.94% | +23.33% | +16.58% | +160.43% | +112.25% | +718.13% | 1.11TCr | |
| -1.74% | +2.91% | - | - | - | - | - | - | - | 956.3Cr | |
| +0.06% | +5.83% | +72.82% | +138.39% | +266.33% | +187.92% | +127.74% | -6.94% | +1,079.28% | 935.32Cr | |
| -4.88% | -18.74% | -26.19% | +45.17% | - | - | - | - | - | 846.14Cr | |
| +0.74% | -.--% | -.--% | -.--% | -.--% | -.--% | +72.26% | +169.06% | - | 819.15Cr | |
| +0.62% | -1.09% | +13.72% | +34.70% | +35.08% | +13.75% | +240.99% | - | - | 821.15Cr | |
| -2.09% | -6.72% | -3.03% | +15.99% | +28.22% | +19.32% | +68.62% | +203.40% | +419.51% | 737.44Cr | |
| -0.35% | -.--% | -0.52% | +93.15% | - | - | - | - | - | 742.9Cr | |
| +0.43% | +0.68% | +1.41% | +44.15% | +130.13% | +125.36% | +623.78% | +450.46% | - | 733.95Cr | |
| +9.02% | +1.00% | +101.99% | +97.28% | +578.93% | +585.81% | +723.53% | +601.21% | - | 761.18Cr | |
| Average | +0.32% | -1.70% | +8.79% | +27.15% | +104.13% | +92.81% | +263.78% | +197.01% | +1,582.02% | 1.66TCr | |
| Weighted average by Cap. | -0.02% | -1.86% | +4.02% | +17.22% | +84.78% | +76.47% | +252.60% | +173.05% | +3,114.30% |
- Stock Market
- Equities
- GMAB Stock
- Sector Genmab A/S
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition